Edward M. Kaye MD

Director, Stoke Therapeutics, Inc.; Director, Cytokinetics

Bought, 12 months

$0.0M

Sold, 12 months

$3.8M

Companies

Latest trade

Aug 18, 2026

Companies

Stoke Therapeutics, Inc.Director −$3.2M CytokineticsDirector −$2.8M

Trades

STOK Sold 12,567 shares at $32.03 $0.4M Aug 18

CYTK Sold 2,933 shares at $76.09 · planned $0.2M Jun 1

STOK Sold 13,430 shares at $32.27 · planned $0.4M Dec 8

STOK Sold 8,548 shares at $31.33 · planned $0.3M Dec 5

STOK Sold 6,453 shares at $30.87 · planned $0.2M Dec 4

STOK Sold 1,070 shares at $30.65 $0.0M Dec 3

STOK Sold 1,066 shares at $29.78 $0.0M Dec 2

CYTK Sold 28,064 shares at $66.72 · planned $1.9M Dec 1

CYTK Sold 5,175 shares at $65.08 · planned $0.3M Nov 11

STOK Sold 25,000 shares at $30.00 · planned $0.8M Oct 8

CYTK Sold 6,757 shares at $60.00 · planned $0.4M Oct 6

STOK Sold 42,461 shares at $25.09 · planned $1.1M Oct 3

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.